Syncom Formulations (India) Ltd. is a key player in the pharmaceutical sector, known for its innovative products and cost-effective solutions. With a current share price of ₹20.12, the company holds promise for future growth. Here’s an in-depth analysis of its share price predictions from 2024 to 2040.
About Syncom Formulations
Syncom Formulations is an Indian pharmaceutical company specializing in manufacturing and marketing formulations across various therapeutic segments. It serves both domestic and international markets, focusing on affordability and quality.
Company Details
Founded: 1988
Headquarters: Indore, Madhya Pradesh, India
Sector: Pharmaceuticals
Products: Tablets, Capsules, Syrups, Ointments
Market Reach: India and Exports
Promoter Details
Promoter Name
Holding (%)
Institutional Investors
12.50
Retail & Others
87.50
Syncom Formulations Share Price Target 2024
Growth Factors:
Expanding export markets.
Focus on affordable healthcare products.
Minimum Target: ₹22
Maximum Target: ₹25
Syncom Formulations Share Price Target 2025
Key Drivers:
Increased investment in R&D for new formulations.
Growth in the domestic healthcare sector.
Minimum Target: ₹28
Maximum Target: ₹32
Syncom Formulations Share Price Target 2026 to 2030
Year
Minimum Target (₹)
Maximum Target (₹)
2026
35
40
2027
42
48
2028
50
58
2029
60
72
2030
75
90
Syncom Formulations Share Price Target 2035
Long-Term Catalysts:
Entry into niche therapeutic areas.
Diversification into over-the-counter (OTC) products.
Minimum Target: ₹110
Maximum Target: ₹135
Syncom Formulations Share Price Target 2040
By 2040, Syncom Formulations is expected to leverage its market presence and innovation to achieve robust growth.
Minimum Target: ₹150
Maximum Target: ₹180
Final Thoughts
Syncom Formulations has the potential to grow steadily in the coming years, driven by its focus on affordable medicines and international expansion. However, stock performance depends on market conditions and the company’s execution of its growth plans.
Disclaimer: Stock market investments are subject to risks. Perform thorough research or consult a financial advisor before investing. For more insights, visit moneyphobia.in!
Recent Posts
Pawan Kumar Chandana: Biography, Age, Education, Net Worth, Wife, Skyroot Aerospace & More
Aryan Kelvin (Aman Pandit): Age, Biography, Height, Village, Net Worth & More
OFSS Bihar Portal 2026: Complete Guide for 11th Admission, Login, Merit List & Spot Admission
Skyroot Aerospace Vikram-1 Launch: India's First Private Orbital Rocket Set for Historic Mission
Abhijeet Dipke Joins Protest at Jantar Mantar, CJP Raises Concerns Over Civil Rights
JPMorgan Invests $24 Million to Boost US Shipbuilding Industry
Offshore Wind Power Faces Fresh Challenges Under Trump Administration Policy
US Gas Prices Edge Higher After Fresh US-Iran Tensions Shake Oil Markets
Reliance Industries Q1 Results 2026: Profit Beats Estimates as Jio and O2C Drive Growth
SBI IPO Allotment Status 2026: How to Check on KFinTech, BSE and NSE
Indian Stocks Show Mixed Earnings as Mideast Worries Trigger Downgrades Says Jefferies - Investing.com
Punjab National Bank stock (INE692A01016): shares firm on latest quarterly results and Indian bankin - AD HOC NEWS